The Roskamp Institute, Inc.

The Roskamp Institute, Inc., a tax-exempt nonprofit biotechnology research organization headquartered in Sarasota, Florida, conducts federally funded preclinical neuroscience research and provides animal research support services to the Department of Veterans Affairs, Defense Health Agency, National Institutes of Health, and Department of the Army as a prime recipient on federal grants and contracts, with 96 percent of recent awards held as prime and the remainder as a sub-recipient.

Roskamp Institute operates across three interconnected capability areas grounded in its award history. The institute pursues hypothesis-driven basic research into neurological and neurodegenerative pathology, including traumatic brain injury (TBI), Alzheimer's disease, Gulf War Illness, and organophosphate neurotoxicity. Representative grant work includes a $1.633 million Defense Health Agency project grant (CFDA 12.420, awarded June 2024, through June 2028) to develop ultraselective DYRK1A inhibitors as a novel therapeutic modality for TBI; a $599,804 National Institute of Neurological Disorders and Stroke project grant (CFDA 93.853, awarded September 2026, through July 2031) investigating apolipoprotein E genotype effects on endothelial nitric oxide synthase regulation and vascular contributions to cognitive impairment and dementia; and a $770,000 Defense Health Agency award (CFDA 12.420, awarded September 2026, through August 2029) to identify immune signatures linked to military-related toxicant exposure as biomarkers for Gulf War Illness diagnosis. Roskamp also provides animal research and veterinary support services to the VA through both task orders and indefinite delivery contracts; a representative $233,751 firm fixed-price delivery order (awarded September 2024 under VA VISN 8, with completion through September 2029) funded within-scope animal research, while a $321,999 single-award IDC base (awarded September 2024, ultimate completion September 2027) establishes the vehicle for ongoing procurement of animal research and support services in Tampa, Florida.

Customer concentration is extreme and single-agency dependent. The VA Veterans Integrated Service Network 8 accounts for 22 of 71 named awards (89 percent of the tracked award portfolio's coverage), representing $4.6 million in combined potential value — all of that concentration sitting in the VA's service contract and veterinary-maintenance delivery orders and IDC task orders. The Defense Health Agency holds the second customer position with 21 awards, followed by the National Institute on Aging (15 awards), the Army Medical Command (11 awards), and the National Institute of Neurological Disorders and Stroke (3 awards). Across recent fiscal years, Roskamp issued five awards in 2026, 11 in 2024, and seven each in 2023 and 2022. Seven awards with combined potential value of $80 thousand face ultimate completion inside the next twenty-four months and therefore present recompete exposure.

Roskamp holds positions on three single-award indefinite delivery contracts with the VA, with combined potential value of approximately $1.196 million across four task orders under IDC 36C24818D0030 ($593 thousand), three task orders under IDC 36C24824D0111 ($585 thousand), and one task order under IDC 36C24821D0088 ($17 thousand). The institute does not hold seats on government-wide acquisition vehicles or multi-agency BPAs; its business model centers on direct prime awards and IDC-based task orders with single customer agencies.

The institute operates as a prime researcher and service provider, holding 78 of 81 recent awards in prime capacity. Sub-award activity is minimal: across three recorded federal grant sub-awards (as named sub-recipient under Boston University and the University of South Florida), Roskamp provided metabolomics and lipidomics analyses and cognitive training support. Service Contract Inventory reporting shows 2 SCI records (both as subcontractor) covering FY2022–FY2024, with 3.9 FTEs delivered in FY2024 and no FTE reporting in FY2022, reflecting the institute's limited exposure on SCI-reportable service contracts above the $150,000 threshold — the institute's federal work is predominantly grants and veterinary/research support services falling outside standard SCI classification. The institute conducts all work in Sarasota and Tampa, Florida.